Skip to main content

Table 2 Baseline HPV prevalence [%] for total cohort according to case–control status and cytology

From: Tumour suppressor gene methylation and cervical cell folate concentration are determinants of high-risk human papillomavirus persistence: a nested case control study

HPV type

 

Cases

   

Controls

  
 

Normal

Borderline

Mild

All

Normal

Borderline

Mild

All

16

29.3

23.0

32.3

28.6a

20.5

23.1

25.3

22.0

18

14.8

19.2

13.13

15.4

13.1

13.3

6.1

11.6

31

11.7

17.3

14.14

13.3

9.5

11.0

2.0

8.3

33

5.0

11.0

8.08

6.9

5.7

12.1

2.0

6.1

35

4.2

6.1

4.04

4.6

3.5

6.6

6.1

4.7

39

9.8

11.0

10.10

10.2

9.2

13.2

13.1

10.8

45

8.1

2.7

9.09

7.1

8.5

5.5

5.1

7.2

51

11.0

12.1

15.15

12.0

9.9

7.7

28.3

13.3

52

18.4

13.0

18.18

17.2a

9.9

22.0

9.1

12.1

56

4.2

5.3

12.12

6.0

8.8

12.1

12.1

10.2b

58

5.0

11.2

17.17

8.7

5.7

3.3

3.0

4.7

59

10.6

6.1

4.04

8.3

7.1

5.5

5.1

6.3

68

3.9

2.6

6.06

3.9

4.6

1.1

5.1

4.0

73

3.5

2.0

2.02

2.9

2.5

4.4

4.0

3.2

82

0.40

1.1

0

0.4

2.8

0.0

0.00

1.7

N

283

100

99

482

283

91

99

473

  1. asignificantly greater than controls, P < 0.02; bsignificantly greater than cases, P < 0.05.